| Local |
BNF | Section |
| Adalimumab | Adalimumab | Eye, Immunosuppressants, Tumor Necrosis Factor Alpha (TNF-A) Inhibitors
Allergic And Inflammatory Eye Conditions, Inflammatory Eye Conditions |
| Adalimumab | Adalimumab | Gastro-Intestinal System, Immunosuppressants, Tumor Necrosis Factor Alpha (TNF-A) Inhibitors
Chronic Bowel Disorders, Inflammatory Bowel Disease |
| Adalimumab | Adalimumab | Musculoskeletal System, Immunosuppressants, Tumor Necrosis Factor Alpha (TNF-A) Inhibitors
Arthritis |
| Adalimumab | Adalimumab | Skin, Immunosuppressants, Tumor Necrosis Factor Alpha (TNF-A) Inhibitors
Inflammatory Skin Conditions, Eczema And Psoriasis |
| Adalimumab | Adalimumab | Skin, Immunosuppressants, Tumor Necrosis Factor Alpha (TNF-A) Inhibitors
Inflammatory Skin Conditions, Hidradenitis Suppurativa |
| Aflibercept | Aflibercept [Specialist Drug] | Eye, Antineovascularisation Drugs, Vascular Endothelial Growth Factor Inhibitors
Macular Oedema, Retinopathy Of Prematurity |
| Aflibercept | Aflibercept [Specialist Drug] | Eye, Antineovascularisation Drugs, Vascular Endothelial Growth Factor Inhibitors
Retinal Disorders, Macular Degeneration |
| Aflibercept | Aflibercept [Specialist Drug] | Malignant Disease, Antineovascularisation Drugs, Vascular Endothelial Growth Factor Inhibitors
Targeted Therapy Responsive Malignancy |
| Apixaban | Apixaban | Cardiovascular System, Antithrombotic Drugs, Factor Xa Inhibitors
Blood Clots, Thromboembolism |
| Brolucizumab | Brolucizumab [Specialist Drug] | Eye, Antineovascularisation Drugs, Vascular Endothelial Growth Factor Inhibitors
Retinal Disorders, Macular Degeneration |
| Brolucizumab | Brolucizumab [Specialist Drug] | Eye, Antineovascularisation Drugs, Vascular Endothelial Growth Factor Inhibitors
Retinal Disorders, Macular Oedema |
| Certolizumab | Certolizumab Pegol | Musculoskeletal System, Immunosuppressants, Tumor Necrosis Factor Alpha (TNF-A) Inhibitors
Arthritis |
| Certolizumab | Certolizumab Pegol | Skin, Immunosuppressants, Tumor Necrosis Factor Alpha (TNF-A) Inhibitors
Inflammatory Skin Conditions, Eczema And Psoriasis |
| Dried | Dried Prothrombin Complex | Cardiovascular System, Blood And Related Products, Coagulation Proteins
Bleeding Disorders, Coagulation Factor Deficiencies |
| Edoxaban | Edoxaban | Cardiovascular System, Antithrombotic Drugs, Factor Xa Inhibitors
Blood Clots, Thromboembolism |
| Etanercept | Etanercept | Musculoskeletal System, Immunosuppressants, Tumor Necrosis Factor Alpha (TNF-A) Inhibitors
Arthritis |
| Etanercept | Etanercept | Skin, Immunosuppressants, Tumor Necrosis Factor Alpha (TNF-A) Inhibitors
Inflammatory Skin Conditions, Eczema And Psoriasis |
| Factor | Factor IX [Specialist Drug] | Cardiovascular System, Blood And Related Products, Coagulation Proteins
Bleeding Disorders, Coagulation Factor Deficiencies |
| Factor | Factor Viia (Recombinant) | Cardiovascular System, Blood And Related Products, Coagulation Proteins
Bleeding Disorders, Coagulation Factor Deficiencies |
| Factor | Factor Viia (Recombinant) | Genito-Urinary System, Blood And Related Products, Coagulation Proteins
Obstetrics, Postpartum Haemorrhage |
| Factor | Factor VIII Fraction, Dried [Specialist Drug] | Cardiovascular System, Blood And Related Products, Coagulation Proteins
Bleeding Disorders, Coagulation Factor Deficiencies |
| Factor | Factor VIII Inhibitor Bypassing Fraction [Specialist Drug] | Cardiovascular System, Blood And Related Products, Haemostatic Products
Bleeding Disorders, Coagulation Factor Deficiencies |
| Factor | Factor XIII A-Subunit (Recombinant) [Specialist Drug] | Cardiovascular System, Blood And Related Products, Coagulation Proteins
Bleeding Disorders, Coagulation Factor Deficiencies |
| Factor | Factor XIII Fraction, Dried [Specialist Drug] | Cardiovascular System, Blood And Related Products, Coagulation Proteins
Bleeding Disorders, Coagulation Factor Deficiencies |
| Faricimab | Faricimab [Specialist Drug] | Eye, Antineovascularisation Drugs, Vascular Endothelial Growth Factor Inhibitors
Retinal Disorders, Macular Degeneration |
| Faricimab | Faricimab [Specialist Drug] | Eye, Antineovascularisation Drugs, Vascular Endothelial Growth Factor Inhibitors
Retinal Disorders, Macular Oedema |
| Fibrinogen, | Fibrinogen, Dried [Specialist Drug] | Cardiovascular System, Blood And Related Products, Coagulation Proteins
Bleeding Disorders, Coagulation Factor Deficiencies |
| Fondaparinux | Fondaparinux Sodium | Cardiovascular System, Antithrombotic Drugs, Factor Xa Inhibitors
Blood Clots, Thromboembolism |
| Fondaparinux | Fondaparinux Sodium | Cardiovascular System, Antithrombotic Drugs, Factor Xa Inhibitors
Myocardial Ischaemia |
| Fresh | Fresh Frozen Plasma | Cardiovascular System, Blood And Related Products, Plasma Products
Bleeding Disorders, Coagulation Factor Deficiencies |
| Garadacimab | Garadacimab | Respiratory System, Factor Xiia Inhibitors
Allergic Conditions, Angioedema |
| Golimumab | Golimumab | Gastro-Intestinal System, Immunosuppressants, Tumor Necrosis Factor Alpha (TNF-A) Inhibitors
Chronic Bowel Disorders, Inflammatory Bowel Disease |
| Golimumab | Golimumab | Musculoskeletal System, Immunosuppressants, Tumor Necrosis Factor Alpha (TNF-A) Inhibitors
Arthritis |
| Infliximab | Infliximab | Gastro-Intestinal System, Immunosuppressants, Tumor Necrosis Factor Alpha (TNF-A) Inhibitors
Chronic Bowel Disorders, Inflammatory Bowel Disease |
| Infliximab | Infliximab | Musculoskeletal System, Immunosuppressants, Tumor Necrosis Factor Alpha (TNF-A) Inhibitors
Arthritis |
| Infliximab | Infliximab | Skin, Immunosuppressants, Tumor Necrosis Factor Alpha (TNF-A) Inhibitors
Inflammatory Skin Conditions, Eczema And Psoriasis |
| Marstacimab | Marstacimab | Cardiovascular System, Antihaemorrhagics, Haemostatics
Bleeding Disorders, Coagulation Factor Deficiencies |
| Protein | Protein C Concentrate [Specialist Drug] | Cardiovascular System, Blood And Related Products, Coagulation Proteins
Bleeding Disorders, Coagulation Factor Deficiencies |
| Ranibizumab | Ranibizumab [Specialist Drug] | Eye, Antineovascularisation Drugs, Vascular Endothelial Growth Factor Inhibitors
Retinal Disorders, Macular Degeneration |
| Ranibizumab | Ranibizumab [Specialist Drug] | Eye, Antineovascularisation Drugs, Vascular Endothelial Growth Factor Inhibitors
Retinal Disorders, Macular Oedema, Diabetic Retinopathy, Retinopathy Of Prematurity |
| Rivaroxaban | Rivaroxaban | Cardiovascular System, Antithrombotic Drugs, Factor Xa Inhibitors
Blood Clots, Thromboembolism |
| Roxadustat | Roxadustat | Blood And Blood-Forming Organs, Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors
Anaemias, Hypoplastic, Haemolytic, And Renal Anaemias |
| Vadadustat | Vadadustat | Blood And Blood-Forming Organs, Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors
Anaemias, Hypoplastic, Haemolytic, And Renal Anaemias |
| Von | Von Willebrand Factor [Specialist Drug] | Cardiovascular System, Blood And Related Products, Coagulation Proteins
Bleeding Disorders, Coagulation Factor Deficiencies |